Giliberto M, Santana LM, Holien T, Misund K, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Coward E, Waage A, Taskén K, Skånland SS(2022) Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines Front Oncol, 12, 1040730 DOI 10.3389/fonc.2022.1040730, PubMed 36523963
Wei Q, Taskén K(2022) Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development Biochem J, 479(20), 2219-2260 DOI 10.1042/BCJ20210233, PubMed 36305711
Flobak Å, Skånland SS, Hovig E, Taskén K, Russnes HG(2022) Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models Trends Pharmacol Sci, 43(11), 973-985 DOI 10.1016/j.tips.2022.08.009, PubMed 36163057